Page last updated: 2024-12-05
bromelia
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
Bromelia: A plant genus of the family BROMELIACEAE. Members contain karatasin and balansain (ENDOPEPTIDASES) and BROMELAINS. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Related Flora
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Bromelia | genus | A plant genus of the family BROMELIACEAE. Members contain karatasin and balansain (ENDOPEPTIDASES) and BROMELAINS.[MeSH] | Bromeliaceae | A plant family of the order Bromeliales, subclass Zingiberidae, class Liliopsida (monocotyledons).[MeSH] |
Cross-References
ID Source | ID |
---|---|
PubMed CID | 7129 |
CHEBI ID | 173790 |
SCHEMBL ID | 111274 |
MeSH ID | M0396901 |
Synonyms (60)
Synonym |
---|
CHEBI:173790 |
ai3-00132 |
brn 2042397 |
ethyl beta-naphthyl ether |
ethyl beta-naphtholate |
beta-naphthol ethyl ether |
nsc 1319 |
beta-naphthyl ethyl ether |
einecs 202-226-7 |
fema no. 2768 |
ethyl-beta-napthylether |
naphthalene, 2-ethoxy- |
wln: l66j co2 |
nerolin (new) |
2-ethoxynaphthalene |
neroline |
ethyl .beta.-naphthyl ether |
nsc-1319 |
bromelia |
2-naphthol ethyl ether |
bromelia (compound) |
.beta.-naphthol ethyl ether |
93-18-5 |
ethyl 2-naphthyl ether |
.beta.-naphthyl ethyl ether |
nerolin new |
nerolin ii |
nsc1319 |
ethyl .beta.-naphtholate |
nerolin bromelia, >=99%, fg |
gumojenffhzafp-uhfffaoysa- |
inchi=1/c12h12o/c1-2-13-12-8-7-10-5-3-4-6-11(10)9-12/h3-9h,2h2,1h3 |
AKOS000280859 |
N0431 |
A844468 |
4-06-00-04257 (beilstein handbook reference) |
unii-zf3is6g3r7 |
zf3is6g3r7 , |
FT-0612215 |
beta-naphthyl ethyl ether [fcc] |
2-ethoxynaphthalene [mi] |
.beta.-naphthyl ethyl ether [fhfi] |
nerolin bromelia |
SCHEMBL111274 |
2-ethoxynapthalene |
DTXSID2049684 |
.beta.-ethoxynaphthalene |
W-100248 |
mfcd00016808 |
2-ethoxynaphthalene, analytical standard |
Z53835291 |
2-ethoxy-naphthalene |
b-naphthyl ethyl ether |
fema 2768 |
beta-ethoxynaphthalene |
Q1371468 |
AS-57148 |
CS-W010770 |
E82989 |
EN300-16134 |
Research Excerpts
Overview
Bromelia balansae is a relatively unexplored medicinal species that is used for nutritional purposes and in folk medicine to treat cough or wounds. Bromelia pinguin L. is a plant broadly distributed in Central America and Caribbean islands.
Effects
Excerpt | Reference | Relevance |
---|---|---|
"Bromelia antiacantha has ornithophilous and melittophilous features, and despite being pollinated by two kinds of agents, its reproductive success depends on a given set of circumstances." | ( The pollination of Bromelia antiacantha (Bromeliaceae) in southeastern Brazil: ornithophilous versus melittophilous features. Canela, MB; Sazima, M, 2005) | 1.38 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Drug Classes (1)
Class | Description |
---|---|
naphthalenes | Any benzenoid aromatic compound having a skeleton composed of two ortho-fused benzene rings. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (63)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (1.59) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 17 (26.98) | 29.6817 |
2010's | 38 (60.32) | 24.3611 |
2020's | 7 (11.11) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 82.03
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (82.03) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (1.49%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 66 (98.51%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |